Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Biochemical and Biophysical Research Communications, 1(471), p. 109-116, 2016

DOI: 10.1016/j.bbrc.2016.01.171

Links

Tools

Export citation

Search in Google Scholar

Ethambutol neutralizes lysosomes and causes lysosomal zinc accumulation

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Ethambutol is a common medicine used for the treatment of tuberculosis, which can have serious side effects, such as retinal and liver dysfunction. Although ethambutol has been reported to impair autophagic flux in rat retinal cells, the precise molecular mechanism remains unclear. Using various mammalian cell lines, we showed that ethambutol accumulated in autophagosomes and vacuolated lysosomes, with marked Zn2+ accumulation. The enlarged lysosomes were neutralized and were infiltrated with Zn2+ accumulations in the lysosomes, with simultaneous loss of acidification. These results suggest that EB neutralizes lysosomes leading to insufficient autophagy, implying that some of the adverse effects associated with EB in various organs may be of this mechanism.